[ad_1]
LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) insider Kevin Michael Mullins sold 46,283 shares of the company’s stock in a transaction on Wednesday, April 20th. The stock was sold at an average price of $10.68, for a total transaction of $494,302.44. Following the completion of the transaction, the insider now directly owns 5,669,472 shares in the company, valued at approximately $60,549,960.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
LFST traded down $0.85 during trading on Friday, reaching $9.54. The stock had a trading volume of 388,789 shares, compared to its average volume of 892,001. The company has a quick ratio of 2.28, a current ratio of 2.28 and a debt-to-equity ratio of 0.10. LifeStance Health Group, Inc. has a one year low of $6.42 and a one year high of $29.81. The business has a 50-day moving average of $9.59 and a 200-day moving average of $9.80.
LifeStance Health Group (NASDAQ:LFST – Get Rating) last posted its quarterly earnings results on Thursday, March 10th. The company reported ($0.32) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.37) by $0.05. LifeStance Health Group had a negative net margin of 46.02% and a negative return on equity of 20.93%. The business had revenue of $190.00 million during the quarter, compared to analyst estimates of $190.35 million. As a group, research analysts expect that LifeStance Health Group, Inc. will post -0.46 earnings per share for the current fiscal year.
Several research analysts have recently weighed in on the stock. UBS Group cut shares of LifeStance Health Group from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $19.00 to $10.00 in a report on Thursday, March 17th. The Goldman Sachs Group decreased their price target on shares of LifeStance Health Group from $15.00 to $10.00 and set a “neutral” rating on the stock in a report on Monday, March 21st. Finally, Zacks Investment Research cut LifeStance Health Group from a “hold” rating to a “sell” rating in a research note on Friday. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $16.00.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Strs Ohio boosted its position in LifeStance Health Group by 226.2% during the first quarter. Strs Ohio now owns 34,900 shares of the company’s stock valued at $352,000 after buying an additional 24,200 shares during the period. CAPROCK Group Inc. boosted its holdings in shares of LifeStance Health Group by 66.7% during the first quarter. CAPROCK Group Inc. now owns 100,000 shares of the company’s stock worth $1,011,000 after purchasing an additional 40,000 shares during the period. Norges Bank purchased a new stake in shares of LifeStance Health Group during the fourth quarter worth about $12,583,000. Wells Fargo & Company MN boosted its holdings in shares of LifeStance Health Group by 7,561.7% during the fourth quarter. Wells Fargo & Company MN now owns 26,203 shares of the company’s stock worth $249,000 after purchasing an additional 25,861 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its holdings in shares of LifeStance Health Group by 20.4% during the fourth quarter. The Manufacturers Life Insurance Company now owns 30,209 shares of the company’s stock worth $288,000 after purchasing an additional 5,121 shares during the period. Institutional investors and hedge funds own 72.58% of the company’s stock.
LifeStance Health Group Company Profile (Get Rating)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Featured Articles
Want More Great Investing Ideas?
Receive News & Ratings for LifeStance Health Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for LifeStance Health Group and related companies with MarketBeat.com’s FREE daily email newsletter.
[ad_2]
Source link